April 12, 2019

Good QOL Outcomes Achieved After Extended Bifrontal Resection for Giant Meningiomas

Pilot study supports routine neuropsychological testing before and after the surgery

Patients who underwent an extended bifrontal approach for resection of a giant anterior cranial base meningioma had improved processing speed postoperatively and no significant changes in nine other neuropsychological quality-of-life (QOL) indicators in a Cleveland Clinic study presented at the 2019 annual meeting of the North American Skull Base Society.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Given the impairment we expect to see with frontal tumors, our findings suggest that the extended bifrontal approach may be an improvement over traditional surgery,” says Cleveland Clinic neurosurgeon Pablo Recinos, MD, senior author of the study. “Neuropsychological testing before and after brain surgery provided important information on quality-of-life parameters.”

Background: Given a good prognosis, QOL gains primacy

Meningiomas are the most common intracranial neoplasm, representing about 40% of cases. Fortunately, WHO grade I meningiomas tend to have a benign course, especially after surgical resection. Often, however, patients have neuropsychological deficits from the tumor, and little is documented about how patients may improve — or worsen — as a result of surgery.

“Traditionally, success in brain tumor treatment is defined by extent of resection, as well as morbidity and mortality after surgery,” says Cleveland Clinic research team member Alankrita Raghavan, who presented the study. “However, because many patients with a meningioma live for decades after treatment, neuropsychological outcomes become a critically important consideration when determining the best surgical approach.”

She adds that QOL outcomes are especially relevant for a giant anterior base meningioma (defined as > 4 cm) because patients usually have considerable cognitive impairment preoperatively. Moreover, the surgery itself is not without risk, especially for such large tumors. Traditional bifrontal craniotomies can require significant brain retraction: Cortical infarction is more likely to occur when retraction pressures are above 20 mmHg and are held for longer than 15 minutes.

Reported outcomes in the literature with traditional surgery include significant postoperative impairments in neuropsychological measures, such as executive function, verbal memory and information processing.

Study design and findings: Assessing extended bifrontal craniotomy

The Cleveland Clinic researchers hypothesized that an extended bifrontal craniotomy would improve neuropsychological outcomes compared with the traditional approach. As shown in the photos below, extended bifrontal craniotomy involves removal of the orbital bar, thereby offering a low trajectory to the base of the tumor, decreasing the need for retraction and reducing edema because of the increased exposure.

Advertisement

Extended bifrontal craniotomy is the removal of the orbital bar

This pilot study involved 16 patients (10 women, mean age 56.3 years, mean tumor diameter 5.78 cm) who underwent an extended bifrontal craniotomy at Cleveland Clinic from 2016 through 2018. Traditional surgical parameters were evaluated, with 10 patients also undergoing neuropsychological assessment, which was designed and directed by neuropsychologist and coinvestigator Richard Naugle, PhD, of Cleveland Clinic’s Center for Behavioral Health.

Six patients had matched pre- and postoperative neuropsychological testing. Preoperative testing was usually performed within a few days of surgery; postoperative testing times varied (median, 90 days postoperatively [range, 84-112]).

The most common presenting symptoms preoperatively were cognitive changes (56%), personality changes (50%), anosmia (37.5%), visual deficits (37.5%) and seizures (25%).

Results of before-and-after neuropsychological testing were as follows:

  • Five (of six) patients improved postoperatively in overall scores.
  • Processing speed significantly improved postoperatively.
  • Improvement in executive function trended toward significance (P = 0.054).
  • Semantic fluency and attention scores decreased postoperatively, although differences were not statistically significant.
  • Visuospatial memory, verbal memory, phonemic fluency, naming and manual dexterity improved postoperatively, although differences were not statistically significant.

A proposal for routine, efficient testing

In view of these findings, Dr. Recinos proposes assessing frontal lobe function in this patient population with a short battery of tests, consisting of:

Advertisement
  • Verbal memory: Hopkins Verbal Learning Test
  • Processing speed: Wechsler Adult Intelligence Scale-IV, coding task
  • Naming: Boston Naming Test (short form)
  • Phonemic fluency: Controlled Oral Word Association Test
  • Executive function: Stroop test, Trails A & B
  • Emotional distress: Beck Depression Inventory

Altogether, complete testing would take only about 40 minutes, he notes, while a standard battery of tests takes more than three times as long.

Dr. Recinos adds that the proposed tests are not the most challenging in each domain. If a patient performed particularly poorly in any area, further specific testing could be done to ascertain a more precise score.

“The results of our small study demonstrate the need for efficient and effective neuropsychological testing that can be routinely administered to evaluate standard and novel surgical approaches,” concludes Dr. Recinos. “Such testing could also help us inform patients which parameters can be expected to change after surgery and which areas may require postoperative rehabilitative therapy.”

Related Articles

Cleveland Clinic physiatrist
March 22, 2024
The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Doctors working on MGUS screening study
March 18, 2024
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access

How antibody drug conjugates work
February 13, 2024
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

Ad